Literature DB >> 9639073

Chemokine receptors in the human brain and their relationship to HIV infection.

E Lavi1, D L Kolson, A M Ulrich, L Fu, F González-Scarano.   

Abstract

Chemokine receptors have been recently identified as the important co-factors which in conjunction with CD4, mediate entry of HIV into its target cells. The brain is one of the most prominent targets of HIV infection, where it leads to HIV encephalitis (HIVE) and HIV-associated dementia. Knowledge of the distribution, physiology, and pathology of chemokines and chemokine receptors in the human brain is fundamental for understanding the pathogenesis of the interaction between HIV and the central nervous system (CNS). There is also increasing evidence that chemokine receptors expression in the CNS increases during pathological, especially inflammatory, conditions. The major co-factors for HIV infection, CCR5, CCR3, and CXCR4 have been detected in the human brain in a variety of cell types including microglia, astrocytes, neurons, and vascular endothelial cells. Furthermore, antibodies to chemokine receptors can also block HIV infectivity in cultured CNS cells. This indicates that chemokine receptors are likely to have a functional role in the pathogenesis of HIVE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639073     DOI: 10.3109/13550289809114531

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  29 in total

Review 1.  Chemokine receptors and neural function.

Authors:  Charlene Cho; Richard J Miller
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  CXCL12 signaling in the development of the nervous system.

Authors:  Divakar S Mithal; Ghazal Banisadr; Richard J Miller
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-21       Impact factor: 4.147

3.  Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.

Authors:  V C Asensio; J Maier; R Milner; K Boztug; C Kincaid; M Moulard; C Phillipson; K Lindsley; T Krucker; H S Fox; I L Campbell
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system.

Authors:  C Gemma; E M Smith; T K Hughes; M R Opp
Journal:  Cell Mol Neurobiol       Date:  2000-08       Impact factor: 5.046

5.  Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.

Authors:  J Martín; C C LaBranche; F González-Scarano
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits.

Authors:  Sheldon R Morris; Steven Paul Woods; Reena Deutsch; Susan J Little; Gabriel Wagner; Erin E Morgan; Robert K Heaton; Scott L Letendre; Igor Grant; Davey M Smith
Journal:  J Neurovirol       Date:  2013-10       Impact factor: 2.643

Review 7.  HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis.

Authors:  Marcus Kaul
Journal:  Front Biosci       Date:  2008-01-01

8.  Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity.

Authors:  O Meucci; A Fatatis; A A Simen; T J Bushell; P W Gray; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 9.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

10.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.